Navigation Links
Commercial yeasts upgraded with an enzyme for biofuel production
Date:2/24/2009

This release is available in German.

Eckhard Boles, co-founder of the Swiss biofuel company Butalco GmbH and a professor at Goethe-University in Frankfurt, Germany, has discovered a new enzyme which teaches yeast cells to ferment xylose into ethanol. Xylose is an unused waste sugar in the cellulosic ethanol production process. The researchers have recently filed a patent application for their process.

In industrial fermentation processes, the yeast Saccharomyces cerevisiae is commonly used for ethanol production. Current bioethanol production technologies can use only parts of the plants, namely the storage sugars, like glucose, sucrose or starch. However, this technology is in competition with food and feed production. Eckhard Boles, co-founder of the Swiss biofuel company Butalco GmbH and a professor at Goethe-University in Frankfurt, Germany, has therefore searched for ways of teaching the microorganisms to convert waste sugars, xylose and arabinose, into ethanol. Now, Boles and his colleagues have succeeded in genetically modifying industrial yeast strains, thus producing ethanol from xylose in a single step. Having already succeeded in transforming arabinose into ethanol by genetically modified yeast strains, Boles and his team have now found an efficient way to convert most of the plants energy into biofuel.

"Up to now scientists considered it as unpromising to equip yeast with a bacterial enzyme capable of converting xylose", Boles explains, "because all attempts had failed". But he and his team continued trying by exploring the enormous amounts of information in current genetic databases. Step by step they took 12 enzymes from different bacterial organisms and inserted the enzymes into yeast cells. Finally they discovered a new enzyme that even worked in yeast cells from a commercial ethanol plant. In contrast to current cellulosic ethanol technologies the new enzyme can convert xylose in a single step and is not inhibited by other chemical compounds normally present within the yeast cells. The researchers have recently filed a patent application for their process. "This is a break-through in the commercialisation of cellulosic ethanol", comments Boles.

Boles says: "We have successfully demonstrated the conversion of waste sugars into ethanol. However, ethanol is not the best renewable biofuel. There are other alcohols with many more promising properties." Together with his company, Butalco GmbH, Boles is now constructing yeast strains to convert plant waste materials into biobutanol, which is being seen as a more superior alternative fuel than ethanol due to its more favourable chemical and physical properties.


'/>"/>

Contact: Eckhard Boles
e.boles@bio.uni-frankfurt.de
49-697-982-9513
Goethe University Frankfurt
Source:Eurekalert

Related biology news :

1. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
2. Commercial aquatic plants offer cost-effective method for treating wastewater
3. MSU technology that converts plant fibers to biofuel commercialized
4. OHSU commercial collaborations have surged
5. Commercialization aim of grant supporting technology that destroys cancer cells
6. Food scientists confirm commercial product effectively kills bacteria in vegetable washwater
7. NOAA proposes rule to prevent commercial harvesting of krill
8. OCAST funds OSU projects with commercial viability
9. IEEE Homeland Security Conference Business Panel to feature experts on technology commercialization
10. UTMB inventions win University of Texas System commercialization awards
11. Computers explain why pears may become brown during commercial storage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce the attainment of record-setting corporate ... of the company,s laser focus on (and growing international ... comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... growth achievements in 2015 include: , Record ...
(Date:1/18/2016)... 2016  Extenua Inc., a pioneering developer of ... and access of ubiquitous on-premise and cloud storage, today ... Cyber.  ... C4ISR and Cyber initiatives in support of National ... technology solutions," said Steve Visconti , Extenua ...
(Date:1/13/2016)... , January 13, 2016 ... published a new market report titled - Biometric Sensors Market ... Forecast, 2015 - 2023. According to the report, the global biometric ... is anticipated to reach US$1,625.8 mn by 2023, expanding ... In terms of volume, the biometric sensors market is ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... held February 8-9, 2016, at the Waldorf Astoria New ... Healthcare Conference, taking place in New York ... Sapirstein , Chief Executive Officer of ContraVir, will provide ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)...  With the growing need for better therapeutics, ... therapies such as monoclonal antibodies, recombinant protein therapeutics ... indications are in high demand. Conventionally expression systems ... production of these therapeutics. However, due to issues ... novel approaches and novel expression systems are currently ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... new office dedicated to the North American healthcare market. , Aerocom Healthcare, LLC ... facilities. The company will provide new pneumatic tube systems or expand existing ...
Breaking Biology Technology: